Pharmaceutical company Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company (NYSE:LLY) reported on Friday the receipt of the European Commission's marketing authorisation for Jardiance tablets for the treatment of type 2 diabetes mellitus (T2D) in adults in Europe.